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Hypotonia-Cystinuria syndrome (HCS) is a rare disease, caused by a mutation in two
contiguous genes (SLC3A1 and PREPL) localized on chromosome 2p21, and it is
characterized by both renal involvement with cystine stones and nervous involvement
with hypotonia. We here describe a 2 years old child with HCS associated with other
clinical features as congenital anomalies of kidney and urinary tract (primary obstructed
megaureter, POM), cryptorchidism and cardiac involvement (patent foramen ovale with
atrial septum aneurysm). To the best of our knowledge, cryporchidism and POM have
never been reported before in patients with HCS. Moreover, a cardiac involvement has
been described only in another case of HCS that, interestingly, presents the same genetic
abnormalities as our patient. The diagnosis of HCS can be difficult because neurological
signs are aspecific and kidney stones are commonly absent during the first months of
life. A better understanding of the complete clinical scenario associated with HCS can
help clinicians suspect, diagnose and treat HCS earlier with a positive influence on both
neurological and renal outcome.
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INTRODUCTION
Hypotonia Cystinuria Syndrome (HCS) is a rare disease, with an estimated prevalence of
1/1.000.000 (1). It is caused by a mutation in two contiguous genes (SLC3A1 and PREPL) localized
on chromosome 2p21, and is characterized by both renal involvement with cystine stones and
nervous system involvement with hypotonia. To date, only 26 cases of HCS are reported in
literature and 8 different deletions have been described.
Cystinuria is an autosomal recessive metabolic disease (with a worldwide prevalence of 1:7.000
newborns) causing urolithiasis, due to mutations in SLC3A1 (Chr 2p21, cystinuria type A) or
SLC7A9 (Chr 19q13.11, cystinuria type B). Both genes are expressed in the renal proximal tubule
and in the intestine and encode for different subunits of the transporter of dibasic amino acids
(cystine, ornithine, lysine, and arginine) (2). Such transporters deficiency leads to an accumulation
of cystine in the urinary tract and to subsequent recurrent stones production, which can eventually
lead to end stage renal disease. The diagnosis of cystinuria is made when typical flat hexagonal
cystine crystals are found in urines or when high levels of urinary cystine (over 300–400 mg/L)
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are detected. Specific genetic tests allow for the identification of
different types of cystinuria. Early diagnosis is crucial because
treatment with tiopronin can prevent stone formation and
chronic kidney disease (3).
PREPL, or prolyl endopeptidase-like gene, encodes for a
protein which belongs to the prolyl oligopeptidase subfamily
of serine peptidases, whose function seems to be related to
the synaptic vesicle exocytosis. It is expressed ubiquitously,
with highest expression in brain, muscle, heart and kidney.
Homozygous deletions of PREPL are associated with generalized
hypotonia similar to Prader-Willi Syndrome. Hypotonia caused
by PREPL deletions can benefit from an early treatment with
pyridostigmine (4).
Diagnosis of HCS can be difficult because neurological signs
are aspecific and kidney stones are commonly absent during
the first months of life. The addition of atypical and novel
clinical cases can lead to a better understanding of the genetic
and clinical basis of the syndrome, and avoid delayed diagnosis
and treatment.
We here report a case of HCS with an atypical
presentation due to the association with cardiac and
genito-urinary involvement.
CASE REPORT
We report the case of a 2 years old child of healthy,
non-consanguineous, Italian parents. All clinical features and
diagnostic work-ups at birth are summarized in Table 1.
Written informed consent was obtained from the participant
for the publication of the case report. Neither urolithiasis nor
neurological/renal diseases were reported in family history. The
pregnancy was characterized by a reduction in fetal movements
from the 25th week of gestation. Fetal growth (expressed as
weight, length and cranial circumference) was on the 25th
percentile during the whole pregnancy. Fetal ultrasound at 20
weeks showed left calyceal dilatation (6mm) and ipsilateral
megaureter (8mm); renal parenchyma and bladder were normal
in thickness and appearance. Amniotic fluid volume was
always adequate.
The child was born at full-term (gestational age 38 weeks,
birth weight 3,350 g, length 51 cm, head circumference 36.8 cm)
by iterative cesarean delivery. At birth, he presented generalized
hypotonia, central cyanosis and bradycardia (APGAR score
5-8-10 at I-V-X minute). Central cyanosis and bradycardia
improved with mask ventilation for 2min while hypotonia
persisted. During the following 24 h a persistent generalized
hypotonia was observed, associated with failure to thrive.
Aspecific dysmorphisms with mild bitemporal narrowing and
frontal bossing, dolichocephaly, micrognathia and a slight ptosis
were also present.
A complete neurologic, metabolic and genetic evaluation was
performed during the first days of life (cerebral ultrasound—
US, spinal and cerebral MRI, EMG, fundus oculi, audiometric
Abbreviations: HCS, Hypotonia Cystinuria Syndrome; CAKUT, Congenital
Anomalies of the Kidney and Urinary Tract; POM, Primary Obstructed
megaureter; POF, patent foramen ovale.
TABLE 1 | Clinical features and diagnostic work-up at birth.
Prenatal history Reduction of fetal movements
Postnatal growth failure
Clinical Examination Generalized hypotonia, failure to thrive.
Bitemporal narrowing, frontal bossing,
dolichocephaly, micrognathia bilateral ptosis.
Left cryptorchidism.
METABOLIC WORK-UP
Plasmatic amino acids
Urinary organic acids
Ammonium
Lactate
Acid/base status
Normal for age
GENETIC TESTS
Karyotype
CGH array
Prader Willi Syndrome
46, XY
Normal
No deletion on chromosome 15
NEUROLOGIC TESTS
Cerebral ultrasound
Spinal and cerebral MRI
EMG
Normal
Cardiologic examination Patent foramen ovale (POF, 1 cm) with left-right
shunt and atrial septum aneurysm.
Abdominal ultrasound Dilatation of the left renal pelvis and ureter (POM),
with an antero-posterior pelvic diameter of 0,8 cm,
a ureteric diameter at bladder junction of 0,7 cm
and normal renal parenchyma and bladder.
test, dosage of plasmatic amino acids, urinary organic acids,
ammonium, lactate, very long chain fatty acids and acid/base
status assessment, renal end hepatic function, karyotype and
CGH array, genetic test for Prader Willi Syndrome). All
these tests didn’t show any specific alteration responsible for
persistent hypotonia.
A cardiologic examination showed the presence of a patent
foramen ovale (POF, 1 cm) with left-right shunt and atrial
septum aneurysm.
The abdominal ultrasound (US) performed at 3 days of
life confirmed a dilatation of the left renal pelvis and ureter
(POM), with an antero-posterior pelvic diameter of 0,8 cm, a
ureteric diameter at bladder junction of 0,7 cm and normal renal
parenchyma and bladder.
Renal US was repeated every 6 months and showed a
worsening of the left hydro-ureteronephrosis, with a distal
and proximal ureter reaching a diameter of 1.4 and 1 cm,
respectively at 18 months. A staghorn stone in the left pelvis
(14 × 15mm) and a stone in the upper ipsilateral ureter (7 ×
16mm) were detected. Moreover, a left palpable undescended
testis was detected.
At that time the child presented with also growth
retardation with weight under the 3rd percentile and
length on the 10th percentile with the need of oro-
gastric tube to allow nutrition. A global developmental
delay of all the motor and social skills and of the
speech was also evident. Neurologic examination revealed
truncal hypotonia.
The child then underwent a cystoscopic examination
with retrograde pyelography that showed a dilated and
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tortuous megaureter due to a severe obstruction of the
uretero-vesical junction that was surgically corrected: it was
not possible to cross the stenosis with a 4,5–6,5 Fr Semi
Rigid Ureterorenoscope, so a ureteroneocystostomy (Politano-
Leadbetter ureteral reimplantation) was performed. In the same
operating session, the ureteral stone was removed and a left
orchidopexy was performed. After 3 months, a percutaneous
nephrolithotripsy was performed to treat the staghorn stone; a
nephrostomy was left and a subsequent anterograde pyelography
showed no uretero-pelvic obstruction and a normal vesico-
ureteral junction after reimplantation. Moreover, in both
cases the analysis of the stone fragments revealed a 100%
cystine composition.
The diagnosis of cystinuria was confirmed by urinary amino
acid examination (cystine/creatinine 676 mMol/mol, normal
value 4–15). Tiopronin (15 mg/kg/day) was immediately started,
along with Potassium Citrate. Given the biochemical diagnosis of
cystinuria and the clinical evidence of hypotonia, MLPA analysis
for SLC3A1 and PREPL deletions was performed in both the
patient and his parents.
The test identified SLC3A1:E7_10del/PREPL:E1-14 deletion
and SLC3A1: E2_E10/PREPL:E4-E14 del in the father’s and
mother’s proband, respectively.
The child inherited father’s and mother’s deletion in SLC3A1
and PREPL with the loss of exons 7–10 in SLC3A1 an 4–14 in
PREPL gene.
After 1 year of treatment, the patient did not show any
recurrence of kidney stones. Neurological work up showed an
improvement in both hypotonia and in dysphagia with no need of
oro-gastric tube after 24 months of life. The patent foramen ovale
with left-right shunt and atrial septum aneurysm still persists
(POF 8mm) at the age of 24 months. Growth impairment is still
present but slowly improving.
DISCUSSION
Several autosomal recessive contiguous gene deletion syndromes
have been described at 2p21 locus and the clinical spectrum
depends on the size of the deletion and on the number of
genes involved: 2p21 deletion syndrome (PPM1B, SLC3A1,
PREPL, C2orf34) (5), HCS syndrome (SLC3A1, PREPL) (1,
6), atypical HCS (SLC3A1, PREPL, C2orf34) (7) and PREPL-
C2orf34deletions (8) (Figure 1).
We here describe the case of a 2 years old child with HCS
and a homozygous deletion in exons 7–10 of SLC3A1 and 4-14
of PREPL. The patient presents HCS with classic neuromuscular
involvement and urolithiasis but also unusual clinical features.
Indeed, the child presents a primary obstructive megaureter
associated with unilateral cryptochidism with also cardiological
involvement (patent foramen ovalewith atrial septum aneurysm).
The pathogenesis of congenital anomalies of the kidney and
urinary tract (CAKUT) is caused by the disturbance of normal
nephrogenesis, secondary to environmental and genetic causes.
The observation of kidney and urinary tract malformations as a
feature of complex genetic syndromes has recently enlightened
the contribution of genetics in CAKUT and is driving research
efforts toward its understanding. So far, some genes have been
identified as responsible of CAKUT phenotypes, being PAX2
FIGURE 1 | Summary of reported deletion in the 2p21 associated to HCS.
*Genetic mutation of the described patient.
and HNF1beta the most commonly identified (9). Nevertheless,
in most cases the genetic basis of CAKUT phenotype remains
unknown. CAKUT genes when mutated can be responsible of
syndromic manifestations, but, so far, none of them has been
described as associated to hypotonia and/or cystinuria.
Our patient presented monolateral cryporchidism and
primary obstructive megaureter (POM) that have never been
reported in patients with HCS. So far, only Bartholdi et al. (10)
described a genitourinary involvement (with hypospadia and
hypoplastic labia majora) as associated to PREPL deletion in
2 cases of 2p21 syndrome with atypical presentation. Among
26 HCS patients from 20 families with nine different deletions
reported so far, only Kiliç et al. (11) have recently described the
association between HCS and cardiac manifestation for the first
time. The authors report a case of HCS associated with dilated
cardiomiopathy in a 7-months-old female with a novel deletion
of PREPL, which corresponds to our patient’s PREPL deletion.
PREPL is highly expressed in the brain and mildly expressed in
the skeletal muscle, heart and kidney (6).
In this context, we cannot exclude that PREPL has a role
in our patient’s phenotype, being highly expressed not only
in the central nervous system and in the striated muscle, but
also in the genitourinary system and in the heart. Only whole
exome sequencing can exclude other genes to be involved in
the phenotype.
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